DUBLIN--(BUSINESS WIRE)--The "Capillary Blood Collection Devices Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Capillary Blood Collection Devices Market ...

The specimen of choice that enables the collection of small blood volumes from neonatal or critically ill patients is a capillary blood specimen. This specimen type has gained favour with many ...

DUBLIN--(BUSINESS WIRE)--The "Capillary Blood Collection Devices Market Analysis Report By Material (Plastic, Glass, Stainless Steel), By Product, By Application (Whole Blood, Plasma Tests), By End ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced that it has entered into a ...

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...

Thanks to the increasing availability of point-of-care (POC) testing, the use of capillary blood (fingerstick) sampling worldwide is growing. Anemia affects around 25% of the global population. Its ...

Please provide your email address to receive an email when new articles are posted on . The BD MiniDraw device is part of a blood testing collection system that is designed to make routine blood tests ...

Background. Reliable reverse transcription polymerase chain reaction (RT-PCR)–based diagnosis of Ebola virus infection currently requires a blood sample obtained by intravenous puncture. During the ...

Yesterday, Hims & Hers Health, Inc. HIMS entered into a definitive agreement to acquire Boston-based YourBio Health, Inc. The ...

Please provide your email address to receive an email when new articles are posted on . “The take-home message is that with the two test kits used in the study, the accuracy of measuring HbA1c from a ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood ...